Isis

ISIS Pharmaceuticals Annual Meeting

Current Advances

Isis Pharmaceuticals' Annual Stockholder Meeting

Upcoming Events

ADA’s 73rd Scientific Sessions

Latest News

06.18.2013

Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House

06.10.2013

Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies